While EGCG downregulated the basal expression of IRF1 mRNA, IFN-γ upregulated its expression (9–21-fold), and this upregulation was reversed by a combination of EGCG and IFN-γ treatment in all three human melanoma cell lines. The gene discussed is IFNG; the disease is melanoma.